Cargando…
Adjusting for treatment selection in phase II/III clinical trials with time to event data
Phase II/III clinical trials are efficient two‐stage designs that test multiple experimental treatments. In stage 1, patients are allocated to the control and all experimental treatments, with the data collected from them used to select experimental treatments to continue to stage 2. Patients recrui...
Autores principales: | Khan, Josephine N., Kimani, Peter K., Glimm, Ekkehard, Stallard, Nigel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098876/ https://www.ncbi.nlm.nih.gov/pubmed/36419206 http://dx.doi.org/10.1002/sim.9606 |
Ejemplares similares
-
Estimation bias in survival data within clinical trials that use adaptive seamless designs
por: Khan, Josephine, et al.
Publicado: (2015) -
Point and interval estimation in two-stage adaptive designs with time to event data and biomarker-driven subpopulation selection
por: Kimani, Peter K., et al.
Publicado: (2020) -
Conditionally unbiased estimation in phase II/III clinical trials with early stopping for futility
por: Kimani, Peter K, et al.
Publicado: (2013) -
Data-driven treatment selection for seamless phase II/III trials incorporating early-outcome data
por: Kunz, Cornelia Ursula, et al.
Publicado: (2014) -
An adaptive seamless phase II/III clinical trial design incorporating short-term endpoint information
por: Stallard, Nigel
Publicado: (2011)